Free Trial
→ Everyone’s watching Nvidia right now. Here’s why I’m excited. (From Timothy Sykes) (Ad)
LON:GENI

GENinCode 6/4/2025 Earnings Report

GENinCode logo
GBX 1.98 +0.09 (+4.47%)
As of 07/18/2025 10:38 AM Eastern
ProfileEarnings History

GENinCode EPS Results

Actual EPS
-GBX 2.53
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GENinCode Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GENinCode Announcement Details

Quarter
Date
6/4/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

GENinCode Earnings Headlines

GENinCode Plc Successfully Passes All Resolutions at AGM
June 30, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/genincode-plc-successfully-passes-all-resolutions-at-agm?utm_source=marketbeat.com&utm_medium=referral
GENinCode shares surge as loss narrows amid increased revenue
June 4, 2025  |  lse.co.ukhttps://www.lse.co.uk/news/genincode-shares-surge-as-loss-narrows-amid-increased-revenue-1yq4cq89uudkq2d.html
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
July 19 at 2:00 AM  |  Crypto Swap Profits (Ad)
Discovering UK Penny Stocks: GENinCode And 2 More Compelling Picks
February 25, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/discovering-uk-penny-stocks-genincode-091105503.html
GENinCode announces retail offer at 5.13% discount
February 14, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/genincode-announces-retail-offer-at-5-13-discount/ar-AA1z26ET
GENinCode secures £4 million in new funding round
February 14, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/genincode-secures-4-million-in-new-funding-round/ar-AA1z2HFt
See More GENinCode Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GENinCode? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GENinCode and other key companies, straight to your email.

About GENinCode

GENinCode (LON:GENI) is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.

View GENinCode Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles